| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |